ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 335

Renal Transplant Complications in Patients with and Without Gout

Megan Francis-Sedlak1, Brian LaMoreaux 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: gout, Renal disease, transplantation and complications

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Graft-related complications are among the most serious issues solid-organ transplant recipients and their healthcare teams face post-operatively. Gout is a known frequent co-morbidity in transplant patients. Whether renal transplant patients with gout suffer from higher rates of transplant-related complications, as compared to transplant patients without gout, has not been investigated. We analyzed a large US population database to determine the overall transplant complication rate in patients having a renal transplant with and without gout.

Methods: A retrospective review of Humana Research Database claims data (2007-2017) was undertaken to identify kidney transplant patients with ≥6 months in plan before and after transplant. Diagnostic gout codes (ICD 9/10) were used to categorize patients into gout and non-gout groups. Additionally patients were classified as having gout pre- or post-transplant based on when the first gout code occurred. Transplant complications were determined using the ICD 9 code for complications of transplanted kidney and ICD 10 codes for unspecified and other complications of kidney transplant, kidney transplant rejection, failure, and infection.

Results: The database contained 6085 patients with a kidney transplant and ≥6 months in plan both pre and post-transplant. Of these, 1504 patients had ≥1 gout codes (the first code occurred in 909 patients pre-transplant and 595 post-transplant), and 4581 patients never had a gout code. The renal transplant complication rate in the overall cohort was 36.0%. Patients with gout had a higher complication rate (40.4%) than those without gout (34.6%, OR: 1.28, 95% CI: 1.136–1.443, p< 0.001). The higher complication rate in gout patients was driven by those who developed gout post-transplant.(Table 1)

Conclusion: Our analysis indicates that patients with gout, especially those with gout arising post-transplant, suffered from higher rates of overall transplant-related complications. In addition to more research on this topic, an increased focus on awareness and screening of renal transplant patients for gout is warranted.

Table 1. Renal transplant-related complications in patients with and without gout


Disclosure: M. Francis-Sedlak, Horizon, 3, 4, Horizon Therapeutics, 3, 4; B. LaMoreaux, Horizon, 3, 4; R. Holt, Horizon, 3, 4, Horizon Therapeutics, 3, 4.

To cite this abstract in AMA style:

Francis-Sedlak M, LaMoreaux B, Holt R. Renal Transplant Complications in Patients with and Without Gout [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/renal-transplant-complications-in-patients-with-and-without-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/renal-transplant-complications-in-patients-with-and-without-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology